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Introduction: Endometrial cancer has been recognised as being an oestrogen-
dependent tumour. However, oestrogen dependency related to growth is lost
during its advancement. Orphan receptors, oestrogen-related receptors (ERR) a,
b, and c, may interact with oestrogen receptor (ER) a and b and may compete
for the use of common ER transcriptional cofactors. This prompted us to study
the expression pattern of the novel orphan receptors, ERR a, b, and c, as well as
ER a and b in endometrial cancer tissues.
Patients and methods: Patients Consent for the following studies was obtained
from all patients and the Research Committee for Human Subjects, Gifu
University School of Medicine, Japan. Tissue samples from endometrial cancers
were collected from 50 patients (stage I, 21 cases; stage II, 16 cases; and stage III,
13 cases; and well-diﬀerentiated endometrioid adenocarcinoma of the endome-
trium [G1], 25 cases; moderately diﬀerentiated endometrioid adenocarcinoma
[G2], 17 cases; and poorly diﬀerentiated endometrioid adenocarcinoma [G3], 8
cases).
Reverse transcription-real time polymerase chain reaction (RT-PCR) to amplify
ERR and ER mRNAs.
Total RNA was extracted from tissue specimens using the acid-phenol
guanidinium method (ISOGNE, Nippon Gene, Tokyo, Japan). PCR reaction
were in a ﬁnal volume of 25 l containing PCR buﬀer (2 mM Tris–HCl, pH 8.0, 10
mM KCl, 10 M ethylenediamine tetraacetic acid, 0.1 mM dithiothreitol, 0.05%
Tween 20, 0.05% Nonidet P-40, 5% glycerol, 3 mM MgCl2), SYBR Green I
(1:30 000 dilution, BioWhittaker Molecular Applications, Rockland, ME,
USA), 0.3 mM deoxyribonucleoside triphosphates (dNTPs), 0.3 M each of the
PCR primers (based on each cDNA sequence) and 1.25 units of Takara Ex
TaqTM R-PCR Version (Takara Suzo, Otsu, Japan). The mixture was ampliﬁed
for 45 PCR cycles (94 C for 10 s (denaturing step), 55 C for 5 s (annealing step)
and 72 C for 20 s (extension step)) in a Smart Cycler (Cepheid, Sunnyvale, CA,
USA).
Results: ER a and b mRNA levels decreased with increasing clinical stage,
myometrial invasion and dediﬀerentiation (Fig. 1). ERR a mRNA levels
increased with clinical stage and myometrial invasion, regardless of dediﬀeren-
tiation. ERR b mRNA levels did not show any speciﬁc relationship with clinical
stage, myometrial invasion or dediﬀerentiation. ERR c mRNA levels increased
with myometrial invasion, regardless of the clinical stage and dediﬀerentiation.
Discussion: In the present study, ER a and b expressions were downregulated in
more advanced tumours and with dediﬀerentiation and myometrial invasion. By
contrast, ERR a and c expression levels were upregulated with myometrial
invasion. The pattern of ERR a and ER a gene expression levels might be due to
competition for the use of common cofactors [1] and loss of oestrogen
dependency. It is speculated that the upregulation of ERR a and b might be
related to tumour growth and invasion in endometrial cancers. ERRs can bind
to the steroid receptor coactivator family without any ligands, and drive
transcriptional activity of the target genes [2]. Transcriptional target genes for
ERR a, including lactoferrin, medium-chain acyl coenzyme A dehydrogenase
and osteopontin have been detected [3,4]. Although expression levels of ERRs
are not directly related to the growth of endometrial cancers, ERR a and c are
candidate prognostic factors in endometrial cancer.
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Fig. 1. Levels of oestrogen receptor (ER) a and b, and oestrogen-related receptor
(ERR) a, b and c mRNAs: A: Tumor limited to endometrium; B: tumor invades
up to less than one half of the myometrium; C: tumor invades more than one
half of the myometrium. *, P< 0.001, ** < 0.05.
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